Cargando…
Construction of a Two-Gene Immunogenomic-Related Prognostic Signature in Lung Squamous Cell Carcinoma
Lung cancer has the highest tumor incidence in China. Lung squamous cell carcinoma (LUSC) is the most common type, accounting for 40–51% of primary lung cancers. LUSC is slow in growth and late in metastasis. Immune-related genes (IRGs) and immune infiltrating cells play a vital role in the clinical...
Autores principales: | Zhang, Xiaoting, Xiao, Jing, Fu, Xian, Qin, Guicheng, Yu, Mengli, Chen, Guihong, Li, Xiaofeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9024339/ https://www.ncbi.nlm.nih.gov/pubmed/35463955 http://dx.doi.org/10.3389/fmolb.2022.867494 |
Ejemplares similares
-
Development of an Immunogenomic Landscape-Based Prognostic Index of Head and Neck Squamous Cell Carcinoma
por: Long, Jinhua, et al.
Publicado: (2020) -
Evaluation of the Prognostic Value of Long Noncoding RNAs in Lung Squamous Cell Carcinoma
por: Zhang, Xiaoting, et al.
Publicado: (2022) -
A novel immunogenomic prognostic signature in lung squamous carcinoma
por: Hou, Jili, et al.
Publicado: (2021) -
Construction and Validation of a Combined Ferroptosis and Hypoxia Prognostic Signature for Hepatocellular Carcinoma
por: Wen, Kai, et al.
Publicado: (2021) -
Exploration of a Robust and Prognostic Immune Related Gene Signature for Cervical Squamous Cell Carcinoma
por: Zuo, Zhihua, et al.
Publicado: (2021)